Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative Oncology Group.

Elena FountzilasGeorgia-Angeliki KoliouAthanassios VozikisVassiliki RaptiAchilleas NikolakopoulosAnastasios BoutisAthina ChristopoulouIoannis KontogiorgosSofia KarageorgopoulouEfthalia LallaDimitrios TryfonopoulosIoannis BoukovinasCleopatra RaptiAdamantia NikolaidiSofia KarteriEvangelia MoirogiorgouIoannis BinasDavide MauriGerasimos AravantinosFlora ZagouriZacharenia SaridakiAmanda PsyrriDimitrios BafaloukosAnna KoumarianouEleni ResHelena LinardouGiannis S MountziosEvangelia RazisGeorge FountzilasGeorgios Koumakis

Published in: ESMO open (2021)

NCT04133207.

Keyphrases

cell cycle
palliative care
electronic health record
oxidative stress
big data
protein kinase
stem cells
cell cycle arrest
cell therapy
mesenchymal stem cells